申请人:California Institute of Technology
公开号:US10005735B2
公开(公告)日:2018-06-26
Candidate compounds for specific inhibition of Rpn11 are represented by Formula 1a
where each of R2, R3, R4, R5, R6, and R7 is independently selected from hydrogen (H), substituted and unsubstituted alkyl groups, carboxyl groups, or substituted and unsubstituted carboxyamides.
特异性抑制 Rpn11 的候选化合物由式 1a 表示
其中 R2、R3、R4、R5、R6 和 R7 各自独立地选自氢(H)、取代和未取代的烷基、羧基或取代和未取代的羧酰胺。